Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction

Charlotte Rietbergen; Gudrun Stefansdottir; Hubert G. Leufkens; Mirjam J. Knol; Marie L. De Bruin; Irene Klugkist

doi:10.3389/fmed.2017.00228

Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction

Charlotte Rietbergen, Gudrun Stefansdottir, Hubert G. Leufkens, Mirjam J. Knol, Marie L. De Bruin, Irene Klugkist

Original language	English
Journal	Frontiers in Medicine
Volume	4
ISSN	2296-858X
DOIs	https://doi.org/10.3389/fmed.2017.00228
Publication status	Published - 2017

Keywords

evidence synthesis
Bayesian inference
informative priors
benefit vs. risk
safety

Access to Document

10.3389/fmed.2017.00228

pdfFinal published version, 616 KBLicence: CC BY

Cite this

@article{08295944919e4afdade54376aa0fe7a1,

title = "Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction",

keywords = "evidence synthesis, Bayesian inference, informative priors, benefit vs. risk, safety",

author = "Charlotte Rietbergen and Gudrun Stefansdottir and Leufkens, {Hubert G.} and Knol, {Mirjam J.} and {De Bruin}, {Marie L.} and Irene Klugkist",

year = "2017",

doi = "10.3389/fmed.2017.00228",

language = "English",

volume = "4",

journal = "Frontiers in Medicine",

issn = "2296-858X",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction

AU - Rietbergen, Charlotte

AU - Stefansdottir, Gudrun

AU - Leufkens, Hubert G.

AU - Knol, Mirjam J.

AU - De Bruin, Marie L.

AU - Klugkist, Irene

PY - 2017

Y1 - 2017

KW - evidence synthesis

KW - Bayesian inference

KW - informative priors

KW - benefit vs. risk

KW - safety

U2 - 10.3389/fmed.2017.00228

DO - 10.3389/fmed.2017.00228

M3 - Journal article

C2 - 29520360

SN - 2296-858X

VL - 4

JO - Frontiers in Medicine

JF - Frontiers in Medicine

ER -

Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction

Keywords

Access to Document

Fingerprint

Cite this